Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2013
07/10/2013CN103201262A Autotaxin inhibitors and uses thereof
07/10/2013CN103201261A Lactam derivatives useful as orexin receptor antagonists
07/10/2013CN103201260A Drug derivatives
07/10/2013CN103194212A Ratio-dependent florescent probe for identifying Zn<2+> and S<2-> in relayed manner as well as synthesis method and application of ratio-dependent florescent probe
07/10/2013CN103193771A New use of drug of chain amide CCR5 (chemokine receptor) receptor antagonist
07/10/2013CN103193765A 1,8-naphthalene imide derivative and preparation method and application thereof
07/10/2013CN103193764A Water-soluble small molecule pyridinium photoelectric material and preparation method and application thereof
07/10/2013CN103193763A Novel preparation method of lenalidomide
07/10/2013CN103193762A Preparation method of alogliptin benzoate
07/10/2013CN103193761A 2-phenyl-6-azolylpyridine-based ligand and group viii transition metal complex
07/10/2013CN103193718A A 4-substituted derivative of 5-bromopyrimidine and a preparation method thereof
07/10/2013CN103193717A Phenylene bipyrimidinyl compound, as well as synthesis method and application thereof
07/10/2013CN103193697A Light-emitting device material and light-emitting device
07/10/2013CN103193572A Separation method of single enantiomer of pantoprazole compound
07/10/2013CN103193568A Selective hydrogenation reduction method of fluorine-containing aromatic hydrocarbon derivative
07/10/2013CN102105461B Insecticidal phenyl- or pyridyl-piperidine compounds
07/10/2013CN102099354B Azole compound
07/10/2013CN102099342B Aminotetrahydroindazoloacetic acids
07/10/2013CN102099341B Aminotetrahydroindazoloacetic acids
07/10/2013CN102086190B Cilostazol compound and novel preparation method thereof
07/10/2013CN102079744B Deuterated achiral crizotinib and derivatives, preparation method and application thereof
07/10/2013CN101910142B Modulators for beta-amyloid
07/10/2013CN101838261B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
07/10/2013CN101687841B Benzimidazole derivatives
07/10/2013CN101638383B Quinoline as well as pharmaceutical composition and use thereof
07/10/2013CN101253166B Sulfonamide compound
07/09/2013US8481750 Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides
07/09/2013US8481744 Process for producing anthranilamide compound
07/09/2013US8481738 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/09/2013US8481731 Compounds, pharmaceutical composition and methods relating thereto
07/09/2013US8481727 Crystals of hydrochloride of pyridazin-3(2H)-one compound and process for production of same
07/09/2013US8481726 Process for the preparation of sterically hindered nitroxyl ethers
07/09/2013US8481585 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
07/09/2013US8481568 Isoindole-imide compounds and compositions comprising and methods of using the same
07/09/2013US8481566 Compounds which have activity at M1 receptor and their uses in medicine
07/09/2013US8481564 Inhibitors of c-fms kinase
07/09/2013US8481548 2-[4-(2-chloro-pyridin-4-ylethynyl)-2-methyl-imidazol-1-yl]-4-trifluoromethyl-pyrimidine; metabotropic glutamate (mGluR5) receptor antagonist; analgesic, neurodegenerative diseases; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain
07/09/2013US8481546 CGRP receptor antagonist
07/09/2013US8481542 Pyridazinyl derivatives as smo inhibitors
07/09/2013US8481539 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
07/09/2013US8481536 Benzotriazine inhibitors of kinases
07/09/2013US8481534 5- and 6-membered heterocyclic compounds
07/09/2013US8481532 PDE-10 inhibitors
07/09/2013US8481531 Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use
07/09/2013US8481526 Fluoroquinolone carboxylic acid molecular crystals
07/09/2013US8481518 Quaternary antimuscarinic compounds for the treatment of bladder diseases
07/09/2013CA2761440C Fredericamycin derivatives
07/09/2013CA2671749C Bicyclic compounds and uses as antidiabetics
07/09/2013CA2580610C Diaminotriazole compounds useful as protein kinase inhibitors
07/09/2013CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
07/09/2013CA2533698C Lanthanide complexes preparation and uses thereof
07/09/2013CA2520323C Tie-2 modulators and methods of use
07/09/2013CA2516407C Heteroarylcarbamoylbenzene derivatives
07/09/2013CA2408408C Modulators of tnf- alpha signaling
07/04/2013WO2013101911A2 Benzimidazole derivatives as selective blockers of persistent sodium current
07/04/2013WO2013101802A1 Nicotinic receptor compounds
07/04/2013WO2013100631A1 Novel imidazopyridine derivatives as a tyrosine kinase inhibitor
07/04/2013WO2013100158A1 Actinic ray-sensitive or radiation-sensitive resin composition, and, actinic ray-sensitive or radiation-sensitive film and pattern forming method, each using the same
07/04/2013WO2013098375A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013WO2013098373A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013WO2013098313A1 Hetero-bicyclic derivatives as hcv inhibitors
07/04/2013WO2013098145A1 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
07/04/2013WO2013097947A1 Pipecolate-sulfonamides for treatment of psychiatric disorders
07/04/2013WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators
07/04/2013WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors
07/04/2013WO2013072528A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)pyridin-3-yl-carboxamide compounds and their use as herbicides
07/04/2013WO2013051024A3 Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (ltc4)
07/04/2013WO2013019561A8 Nuclear transport modulators and uses thereof
07/04/2013US20130172563 Lenalidomide solvates and processes
07/04/2013US20130172550 P2x4 receptor antagonist
07/04/2013US20130172390 Haloalkyl-Substituted Amides as Insecticides and Acaricides
07/04/2013US20130172389 Benzimidazole derivatives as selective blockers of persistent sodium current
07/04/2013US20130172384 Fatty acid synthase inhibitors
07/04/2013US20130172365 Arylosulfonamides for the treatment of cns diseases
07/04/2013US20130172354 Heteroaryl compounds and their uses
07/04/2013US20130172352 5-membered heterocycle-based p38 kinase inhibitors
07/04/2013US20130172351 Dihydropyrazoles
07/04/2013US20130172348 Novel and selective ccr2 antagonists
07/04/2013US20130172347 C5ar antagonists
07/04/2013US20130172346 Use of kynurenic acid amide derivatives for the treatment of huntington's disease
07/04/2013US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
07/04/2013US20130172341 Fused pyrazole derivatives as novel erk inhibitors
07/04/2013US20130172335 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
07/04/2013US20130172330 Chemokine Receptor Modulators
07/04/2013US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c
07/04/2013US20130172317 Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same
07/04/2013US20130172316 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013US20130172315 Substituted anilines as ccr(4) antagonists
07/04/2013US20130172312 Azetidine Derivatives
07/04/2013US20130172310 Benzamides and related inhibitors of factor xa
07/04/2013DE112010005848T5 Amidverbindungen Amide compounds
07/04/2013DE10148438B4 Elektrochrome Vorrichtung Electrochromic device
07/04/2013CA2861202A1 Novel nicotinamide derivative or salt thereof
07/04/2013CA2861013A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors
07/03/2013EP2610252A1 Novel production method for isoquinoline derivatives and salts thereof
07/03/2013EP2610251A1 Novel polymorphic forms of dabigatran etexilate and process for the preparation thereof
07/03/2013EP2610244A1 Indole compounds
07/03/2013EP2609091A1 Pharmaceutically active compounds as axl inhibitors
07/03/2013EP2609084A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 1080